Searches , social queries for 2 OXO-LSD
Search references for 2 OXO-LSD. Phrases containing 2 OXO-LSD
See searches and references containing 2 OXO-LSD!
Search references for 2 OXO-LSD. Phrases containing 2 OXO-LSD
See searches and references containing 2 OXO-LSD!2 OXO-LSD
Pharmaceutical compound
2-Oxo-LSD, also known as 2-oxy-LSD or 2-keto-LSD, or more fully as 2-oxo-2,3-dihydro-LSD, is a lysergamide and metabolite of the psychedelic drug lysergic
2-Oxo-LSD
Pharmaceutical compound
2-Oxo-3-hydroxy-LSD, or 2-oxy-3-hydroxy-LSD, also known as O-H-LSD or OH-LSD, as well as more fully as 2-oxo-3-hydroxy-2,3-dihydro-LSD, is a lysergamide
2-Oxo-3-hydroxy-LSD
Pharmaceutical compound
14-hydroxy LSD metabolites in humans was not completely defined. [...] Recently, iso-LSD, O-H-LSD, Nor-LSD, LAE, LEO, 2-oxo-LSD, 13 and 14-hydroxy-LSD were
13-Hydroxy-LSD
Psychedelic drug
[LSD] is metabolized to the following five metabolites: N-demethyl-LSD (nor-LSD), 2-oxo-LSD, 2-oxo-3-hydroxy-LSD, 13-hydroxy-LSD, and 14-hydroxy-LSD [72–74]
LSD
Pharmaceutical compound
1Fe-LSD, also known as 1-(ferrocenecarbonyl)-LSD or as SYN-L-234, is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide
1Fe-LSD
Precursor for a range of ergoline alkaloids produced by the ergot fungus
of lysergic acid, di-LSD-disulphide [10], nor-LSD, 14-hydroxy-LSD-glucuronide, 14-methoxy-LSD, lumi-LSD or the metabolic 2-oxo-LSD. [...] Preliminary studies
Lysergic_acid
Pharmaceutical compound
of lysergic acid, di-LSD-disulphide [10], nor-LSD, 14-hydroxy-LSD-glucuronide, 14-methoxy-LSD, lumi-LSD or the metabolic 2-oxo-LSD. [...] Preliminary studies
Lumi-LSD
Pharmaceutical compound
of lysergic acid, di-LSD-disulphide [10], nor-LSD, 14-hydroxy-LSD-glucuronide, 14-methoxy-LSD, lumi-LSD or the metabolic 2-oxo-LSD. [...] Preliminary studies
13-Methoxy-LSD
Pharmaceutical compound
of lysergic acid, di-LSD-disulphide [10], nor-LSD, 14-hydroxy-LSD-glucuronide, 14-methoxy-LSD, lumi-LSD or the metabolic 2-oxo-LSD. [...] Preliminary studies
14-Methoxy-LSD
Pharmaceutical compound
isotryptamine-LSD, is a serotonin receptor modulator, psychoplastogen, and serotonergic psychedelic related to lysergic acid diethylamide (LSD). It is the
JRT_(drug)
Common name for more than 1,000 species of flowering plants in the family Convolvulaceae
alkaloids like ergine (LSA) and isoergine, which are structurally related to LSD and can produce psychedelic effects lasting 4 to 10 hours when ingested in
Morning_glory
Class of chemical compounds
lysergamides, also known as deconstructed LSD analogues, are analogues of ergolines and lysergamides like the psychedelic drug LSD in which one or more atoms or bonds
Partial_lysergamide
Index of chemical compounds with the same name
Hydroxy-LSD, also known as OH-LSD or HO-LSD, may refer to: 3-Hydroxy-LSD 12-Hydroxy-LSD 13-Hydroxy-LSD 14-Hydroxy-LSD Lysergic acid ethyl-2-hydroxyethylamide
Hydroxy-LSD
Pharmaceutical compound
Substituted lysergamide 2-Bromo-LSD (BOL-148) MBL-61 (1-methyl-2-bromo-LSD) 2-Oxo-LSD Nichols DE (2018). "Chemistry and Structure-Activity Relationships
2-Iodo-LSD
Fungi of the genus Claviceps
diethylamide (LSD) but instead contains lysergic acid as well as its precursor, ergotamine. Lysergic acid is a precursor for the synthesis of LSD. Their realized
Ergot
Index of chemical compounds with the same name
Methoxy-LSD, also known as OMe-LSD or MeO-LSD, may refer to: 12-Methoxy-LSD 13-Methoxy-LSD 14-Methoxy-LSD LA-MeO Hydroxy-LSD Seco-LSD This set index article
Methoxy-LSD
Index of chemical compounds with the same name
Seco-LSD is an analogue of LSD with one or more bonds removed and may refer to: 3,5-Seco-LSD (UCD0120 or dides-B,C-LSD) 8,10-Seco-LSD (NDTDI) 10,11-Seco-LSD
Seco-LSD
Pharmaceutical compound
UCD0120, also known as dides-B,C-LSD or as 1-deaza-2,3,4-trinor-LSD, is a serotonin 5-HT2 receptor agonist and a cyclized phenethylamine and simplified
UCD0120
Index of chemical compounds with the same name
Des-LSD, or LSD with a part removed, may refer to: Des-A-LSD Des-B-LSD (UCD0068) Des-C-LSD 4-Desmethylene-LSD (UCD0179) 10,11-Seco-LSD (UCD0121) Des-D-LSD
Des-LSD
Pharmaceutical compound
13-Hydroxy-LSD 2-Oxo-LSD 2-Oxo-3-hydroxy-LSD Nichols DE (October 2018). "Dark Classics in Chemical Neuroscience: Lysergic Acid Diethylamide (LSD)" (PDF)
14-Hydroxy-LSD
Chemical compound
1P-LSD, also known as 1-propionyl-LSD, is a psychedelic drug of the lysergamide family related to LSD. It is an amide derivative of LSD and a homologue
1P-LSD
Index of chemical compounds with the same molecular formula
may refer to: Trilyakine 3-Hydroxy-LSD 12-Hydroxy-LSD 13-Hydroxy-LSD 14-Hydroxy-LSD 2-Oxo-LSD Lysergic acid ethyl-2-hydroxyethylamide Methylergometrine
C20H25N3O2
Chemical compound, Novel psychoactive substance analog, LSD prodrug
1S-LSD, also known as 1-(3-(trimethylsilyl)propionyl)-LSD, is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD).
1S-LSD
Chemical compound
LSD. There are no data on how delayed the onset of 1T-LSD may be compared to LSD. Analogues of 1T-LSD include ALD-52 (1A-LSD), 1P-LSD, 1B-LSD, 1V-LSD
1T-LSD
Chemical compound
Analogues of BOL-148 (2-bromo-LSD) include 2-iodo-LSD (IOL, MBL-61 (MOB-61; 1-methyl-2-bromo-LSD), 1-methyl-2-iodo-LSD (MIL), 2-oxo-LSD, and bromocriptine
BOL-148
Pharmaceutical compound
to lysergic acid diethylamide (LSD; METH-LAD). It is specifically a fluorinated derivative of PRO-LAD (6-propyl-6-nor-LSD) and an analogue of FLUORETH-LAD
FP-LAD
Index of chemical compounds with the same name
Iso-LSD (d-iso-LSD, (+)-iso-LSD, or (5R-8S)-LSD) – an inactive stereoisomer l-LSD ((–)-LSD or (5S,8S)-LSD) – an inactive stereoisomer l-Iso-LSD ((–)-iso-LSD
Lysergic acid diethylamide (disambiguation)
Lysergic_acid_diethylamide_(disambiguation)
Pharmaceutical compound
3-dihydro-LSD used by Gorodetzky and Isbell in their clinical study. Substituted lysergamide 9,10-Dihydro-LSD 2-Oxo-LSD 2-Oxo-3-hydroxy-LSD Gorodetzky
2,3-Dihydro-LSD
Pharmaceutical compound
lysergic acid diethylamide. [...] Iso-LSD, 2-oxo-3-OH-LSD, nor-LSD, LAE, LEO, 13/14-hydroxy-LSD, and 2-oxo-LSD could be detected only sporadically, and
Iso-LSD
Pharmaceutical compound
(LSD). It is the analogue of LSD in which one of the ethyl groups on the amide has been replaced with an ethenyl (vinyl) group. Didehydro-LSD (DDH-LSD)
TRALA-12
Pharmaceutical compound
related to lysergic acid diethylamide (LSD). It is the N-(2-methoxybenzyl) (NBOMe) derivative of LSD. NBOMe-LAD is known to act as an agonist of the serotonin
NBOMe-LAD
Dopamine agonist medication
The chemical structure of the LSD metabolite 2-oxo-LSD is slightly related, and a notable analogue is DPAI (2-desoxo-2-ene-ropinirole). Chemical structures
Ropinirole
Pharmaceutical compound
the lysergamide family related to lysergic acid diethylamide (LSD). It is an analogue of LSD in which the N,N-diethyl groups have been fused together to
LA-Aziridine
Pharmaceutical compound
of lysergic acid, di-LSD-disulphide [10], nor-LSD, 14-hydroxy-LSD-glucuronide, 14-methoxy-LSD, lumi-LSD or the metabolic 2-oxo-LSD. [...] Preliminary studies
Nor-LSD
Species of fungus
acid diethylamide (LSD) but rather ergotamine, which is used to synthesize lysergic acid, an analog of and precursor for synthesis of LSD. Moreover, ergot
Claviceps_purpurea
Chemical compound
lysergamides: 1P-BOL-148 2-Bromo-LSD (bromolysergide; BOL-148) 2-Iodo-LSD 2-Oxo-LSD (2-keto-LSD) 2-Oxo-3-hydroxy-LSD 9,10-Dihydro-LSD Amesergide AWD 52-39
Agroclavine
Chemical compound
rodents with similar potency as 1P-LSD. Related compounds include 1B-LSD, 1DD-LSD, 1P-LSD, 1V-LSD, ALD-52 (1A-LSD), 1cP-AL-LAD, AL-LAD, ETH-LAD, 1P-ETH-LAD
1cP-LSD
Pharmaceutical compound
CE-LAD, or CHLORETH-LAD, also known as 6-(2-chloroethyl)-LAD or 6-(2-chloroethyl)-6-nor-LSD, is a compound of the lysergamide family related to the serotonergic
CE-LAD
Pharmaceutical compound
LA-Azepane, or LSD-Azepane, also known as lysergic acid azepane or as lysergic acid hexamethylene imide, is a chemical compound of the lysergamide family
LA-Azepane
Index of chemical compounds with the same name
Dihydro-LSD (DH-LSD), also known as dihydro-lysergic acid diethylamide, may refer to: 2,3-Dihydro-LSD 9,10-Dihydro-LSD This set index article lists chemical
Dihydro-LSD
Pharmaceutical compound
UCD0179, also known as 4-desmethylene-LSD or 3,5-seco-LSD, is an indole derivative and a "partial" or simplified lysergamide which is closely related
UCD0179
Species of plant
seed and not the seed protectant. The LSD-like reaction is most likely due to the LSD-like alkaloids for no pure LSD has as yet been isolated from the seed
Ipomoea_tricolor
Index of chemical compounds with the same name
5-Secoergoline (RU-27251) 8,10-Secoergoline (e.g., 8,10-seco-LSD (NDTDI)) 10,11-Secoergoline (e.g., 10,11-seco-LSD (UCD0121), CT-5252) Other secoergolines include
Secoergoline
Chemical compound
(1A-LSD) include MLD-41 (1-methyl-LSD), OML-632 (1-hydroxymethyl-LSD), ALA-10 (1A-LAE), 1-formyl-LSD, 1P-LSD, 1cP-LSD, 1V-LSD, 1B-LSD, 1S-LSD, 1T-LSD, 1P-ETH-LAD
ALD-52
Species of flowering plant
lysergamides: 1P-BOL-148 2-Bromo-LSD (bromolysergide; BOL-148) 2-Iodo-LSD 2-Oxo-LSD (2-keto-LSD) 2-Oxo-3-hydroxy-LSD 9,10-Dihydro-LSD Amesergide AWD 52-39
Ipomoea_asarifolia
Chemical compound
(LSD). It is an analogue of LSD and is thought to act as a prodrug of LSD. The drug has been encountered as a novel designer recreational drug. 1V-LSD
1V-LSD
Pharmaceutical compound
N-dimethyl-2-aminotetralin (N,N-DiMe-2-AT), is a serotonin receptor modulator of the 2-aminotetralin family. It is the N,N-dimethyl derivative of 2-aminotetralin
UCD0830
Chemical compound
an analogue of LSD originally researched by David E. Nichols and colleagues at Purdue University. It has similar binding affinity to LSD itself as both
Lysergic_acid_3-pentylamide
Index of chemical compounds with the same name
Nor-LSD, also known as nor-lysergic acid diethylamide, may refer to: Nor-LSD (6-nor-LSD) NDTDI (9-nor-LSD; 9-desmethine-LSD; 8,10-seco-LSD) UCD0179 (4-nor-LSD;
Nor-LSD_(disambiguation)
lysergamides: 1P-BOL-148 2-Bromo-LSD (bromolysergide; BOL-148) 2-Iodo-LSD 2-Oxo-LSD (2-keto-LSD) 2-Oxo-3-hydroxy-LSD 9,10-Dihydro-LSD Amesergide AWD 52-39
Ergosine
Pharmaceutical compound
1Bz-LSD, also known as 1-benzoyl-LSD or as SYN-L-018, is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD). It is
1Bz-LSD
Pharmaceutical compound
lysergamide and is a derivative of 2C-D with a lysergic acid diethylamide (LSD)-like N-(3-diethylamino-3-oxopropyl)- substitution. The compound was assessed
25D-NM-NDEAOP
Chemical compound
also known as 6-ethyl-6-nor-LSD, is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD; also known as METH-LAD). It
ETH-LAD
Pharmaceutical compound
"1-methoxy-LSD" or "1-MeO-LSD" in some publications. Substituted lysergamide MLD-41 (1-methyl-LSD) ALD-52 (1-acetyl-LSD) 1P-LSD (1-propionyl-LSD) Shulgin
OML-632
Chemical compound
also known as 9-desmethine-LSD, 9-nor-LSD, or 8,10-seco-LSD, is a psychedelic drug related to lysergic acid diethylamide (LSD). It is a tricyclic cyclized
NDTDI
Chemical compound in the ergot family of alkaloids
S2CID 22721405. PDSP Database – UNC Kehler J, Lindskov MS (May 2025). "Are the LSD-analogs lisuride and ergotamine examples of non-hallucinogenic serotonin
Ergotamine
Pharmaceutical compound
(2023). "Identification of LSD analogs, 1cP-AL-LAD, 1cP-MIPLA, 1V-LSD and LSZ in sheet products" (PDF). Forensic Toxicology. 41 (2): 294–303. doi:10.1007/s11419-023-00661-1
1cP-MiPLA
Pharmaceutical compound
lysergamide family related to lysergic acid diethylamide (LSD; LSD-25). It is the analogue of LSD in which one of the N-ethyl groups has been replaced with
LME-54
Pharmaceutical compound
for determining 15 designer LSD analogs in biological samples with application to stability studies". The Analyst. 150 (2): 290–308. Bibcode:2025Ana.
1P-MiPLA
Pharmaceutical compound
of LSD. l-LSD, also known as (–)-LSD or (5S,8S)-LSD, is one of four possible stereoisomers. The other isomers are LSD (d-LSD, (+)-LSD, or (5R,8R)-LSD),
L-LSD
Pharmaceutical compound
to lysergic acid diethylamide (LSD). It is the O-methyl ether derivative of the LSD metabolite lysergic acid ethyl-2-hydroxyethylamide (LEO). The drug
LA-MeO
Class of chemical compounds
LSD, such as the psychedelics ALD-52 (1A-LSD), ETH-LAD, LSZ, and 1P-LSD and the non-hallucinogenic 2-bromo-LSD (BOL-148), have also been developed. Ergopeptines
Lysergamides
Pharmaceutical compound
(N-propyl-9-oxaergoline) and pergolide". European Journal of Pharmacology. 87 (2–3): 183–189. doi:10.1016/0014-2999(83)90328-x. PMID 6857756. The relatively
RU-29717
Psychedelic drug
psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD). It is taken orally. The drug acts as a non-selective serotonin receptor
LSZ
Pharmaceutical compound
ALD-52 is LSD. ALA-10 is active at a dose of approximately 1.2 mg orally in humans and has around 7 to 10% of the potency of LSD. It produces LSD-like psychic
ALA-10
Pharmaceutical compound
org/library/books_online/tihkal/tihkal26.shtml "1-Hydroxymethyl-LSD, 1-dimethylaminomethyl-LSD and 2-iodo-LSD. These three additional compounds are shown here because
1-Dimethylaminomethyl-LSD
Pharmaceutical compound
DOTFM. The drug can also be thought of as a derivative of DOTFM with an LSD-like N,N-diethylamide moiety. A quantitative structure–activity relationship
DOTFM-NDEPA
Chemical compound
lysergamides: 1P-BOL-148 2-Bromo-LSD (bromolysergide; BOL-148) 2-Iodo-LSD 2-Oxo-LSD (2-keto-LSD) 2-Oxo-3-hydroxy-LSD 9,10-Dihydro-LSD Amesergide AWD 52-39
Penniclavine
Pharmaceutical compound
known as 1-methyl-2-bromo-LSD, is a serotonin receptor modulator of the lysergamide family related to lysergic acid diethylamide (LSD). It is the 1-methyl
MBL-61
Chemical compound
psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD). It is an isomer of ETH-LAD. EiPLA has been identified in blotter containing
EiPLA
Pharmaceutical compound
It was developed for treatment of Parkinson's disease and reached phase 2 clinical trials for this indication. The drug was discontinued due to inadequate
Naxagolide
Pharmaceutical compound
lysergamides: 1P-BOL-148 2-Bromo-LSD (bromolysergide; BOL-148) 2-Iodo-LSD 2-Oxo-LSD (2-keto-LSD) 2-Oxo-3-hydroxy-LSD 9,10-Dihydro-LSD Amesergide AWD 52-39
Brazergoline
Pharmaceutical compound
position. FAEFHI can also be thought of as a greatly simplified analogue of LSD and hence partial ergoline. Although FAEFHI shows significant affinity for
FAEFHI
Pharmaceutical compound
in the scientific literature by 1983. Partial ergoline Secoergoline Seco-LSD FAEFHI UCD0179 WXVL_BT0793LQ2118 Osman R, Mazurek AP, Weinstein H (1987)
RU-27251
Ergot alkaloid and serotonin receptor agonist
lysergamides: 1P-BOL-148 2-Bromo-LSD (bromolysergide; BOL-148) 2-Iodo-LSD 2-Oxo-LSD (2-keto-LSD) 2-Oxo-3-hydroxy-LSD 9,10-Dihydro-LSD Amesergide AWD 52-39
Lysergine
Chemical compound
related to lysergic acid diethylamide (LSD). LSM-775 is less potent than LSD but is reported to have some LSD-like effects at doses ranging from 75 to
LSM-775
Pharmaceutical compound
(NCPe-LA) or as lysergic acid cyclopentylamide (LCyP), is an analogue of LSD developed in the former Soviet Union which acts as an antagonist at serotonin
Cepentil
Chemical compound
beta-dihydroergocryptine). It was developed by Albert Hofmann (the discoverer of LSD) for Sandoz (now part of Novartis). It has been used to treat dementia and
Ergoloid
Pharmaceutical compound
lysergamide family related to lysergic acid diethylamide (LSD). It is the analogue of LSD in which the amide group has two propyl substitutions instead
Lysergic_acid_dipropylamide
Pharmaceutical compound
of lysergic acid, di-LSD-disulphide [10], nor-LSD, 14-hydroxy-LSD-glucuronide, 14-methoxy-LSD, lumi-LSD or the metabolic 2-oxo-LSD. Slaytor MB, Wright
12-Hydroxy-LSD
Pharmaceutical compound
respectively). Analogues of 1D-LSD include ALD-52 (1A-LSD), 1P-LSD, 1S-LSD, 1DD-LSD, 1V-LSD, 1cP-LSD, and 1T-LSD, among others. 1D-LSD was encountered online
1D-LSD
Pharmaceutical compound
10,11-Seco-LSD, also known as UCD0121, is a partial lysergamide and cyclized tryptamine related to lysergic acid diethylamide (LSD). It is the seco analogue
10,11-Seco-LSD
Species of fungus
lysergamides: 1P-BOL-148 2-Bromo-LSD (bromolysergide; BOL-148) 2-Iodo-LSD 2-Oxo-LSD (2-keto-LSD) 2-Oxo-3-hydroxy-LSD 9,10-Dihydro-LSD Amesergide AWD 52-39
Periglandula_turbinae
Pharmaceutical compound
lysergamides and has elements of the chemical structure of LSD and related psychedelic lysergamides like LSD-Pip within its structure. 25B-NAcPip may or may not
25B-NAcPip
Chemical compound
lysergamides: 1P-BOL-148 2-Bromo-LSD (bromolysergide; BOL-148) 2-Iodo-LSD 2-Oxo-LSD (2-keto-LSD) 2-Oxo-3-hydroxy-LSD 9,10-Dihydro-LSD Amesergide AWD 52-39
Ergovaline
Pharmaceutical compound
derivative of LSD in which one of its N-ethyl groups of LSD has been hydroxylated at the end or 2 position. It is also an active metabolite of LSD including
Lysergic acid ethyl-2-hydroxyethylamide
Lysergic_acid_ethyl-2-hydroxyethylamide
Pharmaceutical compound
DiPLA showed 23.2% of the antiserotonergic activity of LSD in the isolated rat uterus and hence was about 4-fold less potent than LSD in this assay. Subsequently
DiPLA
Chemical compound
lysergamides: 1P-BOL-148 2-Bromo-LSD (bromolysergide; BOL-148) 2-Iodo-LSD 2-Oxo-LSD (2-keto-LSD) 2-Oxo-3-hydroxy-LSD 9,10-Dihydro-LSD Amesergide AWD 52-39
Dihydroergocristine
Pharmaceutical compound
similar manner to how 1P-LSD acts as a prodrug for LSD. Analogues of 1T-AL-LAD include AL-LAD, 1P-AL-LAD, 1cP-AL-LAD, 1T-LSD, 1S-LSD, and 1P-ETH-LAD, among
1T-AL-LAD
Pharmaceutical compound
as 6-methallyl-6-nor-LSD, is a serotonin receptor modulator of the lysergamide family related to lysergic acid diethylamide (LSD). The drug acts as a
MAL-LAD
Chemical compound
6-propynyl-6-nor-LSD or 6-propargyl-6-nor-LSD, is a psychedelic drug of the lysergamide family related to lysergic acid diethylamide (LSD). PARGY-LAD is
PARGY-LAD
Chemical compound
of pergolide, ropinirole and CY 208-243". Behavioural Brain Research. 156 (2): 173–9. doi:10.1016/j.bbr.2004.05.019. PMID 15582103. S2CID 10255277. v t
CY-208,243
Pharmaceutical compound
to 5 to 58% for ergine. Albert Hofmann, the discoverer of LSD's psychedelic effects, tried 2 mg isoergine orally and experienced feelings of unreality
Isoergine
Chemical compound
lysergamides: 1P-BOL-148 2-Bromo-LSD (bromolysergide; BOL-148) 2-Iodo-LSD 2-Oxo-LSD (2-keto-LSD) 2-Oxo-3-hydroxy-LSD 9,10-Dihydro-LSD Amesergide AWD 52-39
Lysergene
Chemical compound
lysergamide family related to lysergic acid diethylamide (LSD). It is the analogue of LSD in which the N,N-diethylamide moiety has been cyclized into
LPD-824
Chemical compound
1DD-LSD include ALD-52 (1A-LSD), 1P-LSD, 1B-LSD, 1H-LSD, and 1V-LSD, among others. 1DD-LSD is not a controlled substance in Canada as of 2025. 1DD-LSD is
1DD-LSD
Chemical compound
"Lergotrile in Parkinson disease: further studies". Neurology. 29 (2): 267–72. doi:10.1212/wnl.29.2.267. PMID 34808. Cunningham KA, Callahan PM, Appel JB (July
Lergotrile
Pharmaceutical compound
vasoconstriction. The pharmacokinetics and tolerability of XC-101 at doses of 0.2 to 0.5 mg orally in humans have been studied. Besides XC-101, its developer
XC-101
Chemical compound
Because of the existing Controlled Substances Act regulatory controls on the LSD precursors lysergic acid, lysergic acid amide, ergotamine, and ergonovine
Ergocristine
Pharmaceutical compound
drug DOB. The drug can also be thought of as a derivative of DOB with an LSD-like N,N-diethylamide moiety. A quantitative structure–activity relationship
DOB-NDEPA
travel, tourism, insurance
2 OXO-LSD
2 OXO-LSD
2 OXO-LSD
2 OXO-LSD
2 OXO-LSD
2 OXO-LSD
2 OXO-LSD
2 OXO-LSD
2 OXO-LSD
travel, tourism, insurance